Ghazaleh Tabatabai (G Tabatabai)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Venues

Neuro-oncology

Journal of neuro-oncology

Cancers

Neuro-oncology advances

Eberhard Karls Universität Tübingen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eberhard Karls Universität Tübingen Jul 01 2014

Germany

Professor :: Neurology & Neurooncology

Publications

Foteini Tsiami, Chiara Lago, Noemi Pozza, Frederica Piccioni, Xuesong Zhao, Fabienne Lülsberg, David E Root, Luca Tiberi, Marcel Kool, Cornelia Brendle, Pratiti Bandopadhayay, Rosalind A Segal, Ghazaleh Tabatabai, Daniel J Merk
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma. Acta neuropathologica communications 12 (1) (2024)
Bianca Walter, Sophie Hirsch, Laurence Kuhlburger, Aaron Stahl, Leonard Schnabel, Silas Wisser, Lara A Haeusser, Foteini Tsiami, Sarah Plöger, Narges Aghaallaei, Advaita M Dick, Julia Skokowa, Christian Schmees, Markus Templin, Katja Schenke-Layland, Marcos Tatagiba, Sven Nahnsen, Daniel J Merk, Ghazaleh Tabatabai
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Daniel J Merk, Linda Paul, Foteini Tsiami, Helen Hohenthanner, Ghazal Mohseni Kouchesfahani, Lara A Haeusser, Bianca Walter, Adam Brown, Nicole S Persky, David E Root, Ghazaleh Tabatabai
CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines. Genome medicine 16 (1) (2024)
Foteini Tsiami, Chiara Lago, Noemi Pozza, Frederica Piccioni, Xuesong Zhao, Fabienne Lülsberg, David E Root, Luca Tiberi, Marcel Kool, Cornelia Brendle, Pratiti Bandopadhayay, Rosalind A Segal, Ghazaleh Tabatabai, Daniel J Merk
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma. Acta neuropathologica communications 12 (1) (2024)
Daniel Feucht, Patrick Haas, Marco Skardelly, Felix Behling, David Rieger, Paula Bombach, Frank Paulsen, Elgin Hoffmann, Till-Karsten Hauser, Benjamin Bender, Mirjam Renovanz, Maximilian Niyazi, Ghazaleh Tabatabai, Marcos Tatagiba, Constantin Roder
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival. Neuro-oncology advances 6 (1) (2024)
Bianca Walter, Sophie Hirsch, Laurence Kuhlburger, Aaron Stahl, Leonard Schnabel, Silas Wisser, Lara A Haeusser, Foteini Tsiami, Sarah Plöger, Narges Aghaallaei, Advaita M Dick, Julia Skokowa, Christian Schmees, Markus Templin, Katja Schenke-Layland, Marcos Tatagiba, Sven Nahnsen, Daniel J Merk, Ghazaleh Tabatabai
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Foteini Tsiami, Chiara Lago, Noemi Pozza, Frederica Piccioni, Xuesong Zhao, Fabienne Lülsberg, David E Root, Luca Tiberi, Marcel Kool, Cornelia Brendle, Pratiti Bandopadhayay, Rosalind A Segal, Ghazaleh Tabatabai, Daniel J Merk
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma. Acta neuropathologica communications 12 (1) (2024)
Bianca Walter, Sophie Hirsch, Laurence Kuhlburger, Aaron Stahl, Leonard Schnabel, Silas Wisser, Lara A Haeusser, Foteini Tsiami, Sarah Plöger, Narges Aghaallaei, Advaita M Dick, Julia Skokowa, Christian Schmees, Markus Templin, Katja Schenke-Layland, Marcos Tatagiba, Sven Nahnsen, Daniel J Merk, Ghazaleh Tabatabai
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Daniel J Merk, Linda Paul, Foteini Tsiami, Helen Hohenthanner, Ghazal Mohseni Kouchesfahani, Lara A Haeusser, Bianca Walter, Adam Brown, Nicole S Persky, David E Root, Ghazaleh Tabatabai
CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines. Genome medicine 16 (1) (2024)
Daniel Feucht, Patrick Haas, Marco Skardelly, Felix Behling, David Rieger, Paula Bombach, Frank Paulsen, Elgin Hoffmann, Till-Karsten Hauser, Benjamin Bender, Mirjam Renovanz, Maximilian Niyazi, Ghazaleh Tabatabai, Marcos Tatagiba, Constantin Roder
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival. Neuro-oncology advances 6 (1) (2024)
David Capper, Guido Reifenberger, Pim J French, Leonille Schweizer, Michael Weller, Mehdi Touat, Simone P Niclou, Philipp Euskirchen, Christine Haberler, Monika E Hegi, Sebastian Brandner, Emilie Le Rhun, Roberta Rudà, Marc Sanson, Ghazaleh Tabatabai, Felix Sahm, Patrick Y Wen, Pieter Wesseling, Matthias Preusser, Martin J van den Bent
EANO guideline on rational molecular testing of gliomas, glioneuronal and neuronal tumors in adults for targeted therapy selection. Neuro-oncology (2023)
Michael Weller, Emilie Le Rhun, Martin Van den Bent, Susan M Chang, Timothy F Cloughesy, Roland Goldbrunner, Yong-Kil Hong, Rakesh Jalali, Michael D Jenkinson, Giuseppe Minniti, Motoo Nagane, Evangelia Razis, Patrick Roth, Roberta Rudà, Ghazaleh Tabatabai, Patrick Y Wen, Susan C Short, Matthias Preusser
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro-oncology (2023)
Mirjam Renovanz, Sylvia C Kurz, Johannes Rieger, Bianca Walter, Hannes Becker, Hanni Hille, Paula Bombach, David Rieger, Lucia Grosse, Lara Häusser, Marco Skardelly, Daniel J Merk, Frank Paulsen, Elgin Hoffmann, Cihan Gani, Manuela Neumann, Rudi Beschorner, Olaf Rieß, Cristiana Roggia, Christopher Schroeder, Stephan Ossowski, Sorin Armeanu-Ebinger, Axel Gschwind, Saskia Biskup, Martin Schulze, Falko Fend, Stephan Singer, Lars Zender, Claudia Lengerke, Sara Yvonne Brucker, Tobias Engler, Andrea Forschner, Arnulf Stenzl, Oliver Kohlbacher, Sven Nahnsen, Gisela Gabernet, Sven Fillinger, Benjamin Bender, Ulrike Ernemann, Öznur Öner, Janina Beha, Holly Sundberg Malek, Yvonne Möller, Kristina Ruhm, Marcos Tatagiba, Cornelia Brendle, Michael Bitzer, Nisar Malek, Daniel Zips, Ghazaleh Tabatabai
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. Neuro-oncology advances 5 (1) (2023)
Vítor Moura Gonçalves, Elisa-Maria Suhm, Vanessa Ries, Marco Skardelly, Ghazaleh Tabatabai, Marcos Tatagiba, Cornelia Brendle, Felix Behling
Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13 , 466. Cancers 15 (2) (2023)
Johannes M Weller, N Schäfer, C Schaub, Theophilos Tzaridis, T Zeyen, Matthias Schneider, Anna-Laura Potthoff, F A Giordano, J P Steinbach, P S Zeiner, T Kowalski, M Sabel, P Hau, D Krex, O Grauer, R Goldbrunner, O Schnell, Ghazaleh Tabatabai, Florian Ringel, F Schmidt-Graf, S Brehmer, J C Tonn, L Bullinger, P Vajkoczy, M Glas, H Vatter, U Herrlinger, C Seidel
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial. Journal of neuro-oncology 161 (1) (2023)
Mirjam Renovanz, Sylvia C Kurz, Johannes Rieger, Bianca Walter, Hannes Becker, Hanni Hille, Paula Bombach, David Rieger, Lucia Grosse, Lara Häusser, Marco Skardelly, Daniel J Merk, Frank Paulsen, Elgin Hoffmann, Cihan Gani, Manuela Neumann, Rudi Beschorner, Olaf Rieß, Cristiana Roggia, Christopher Schroeder, Stephan Ossowski, Sorin Armeanu-Ebinger, Axel Gschwind, Saskia Biskup, Martin Schulze, Falko Fend, Stephan Singer, Lars Zender, Claudia Lengerke, Sara Yvonne Brucker, Tobias Engler, Andrea Forschner, Arnulf Stenzl, Oliver Kohlbacher, Sven Nahnsen, Gisela Gabernet, Sven Fillinger, Benjamin Bender, Ulrike Ernemann, Öznur Öner, Janina Beha, Holly Sundberg Malek, Yvonne Möller, Kristina Ruhm, Marcos Tatagiba, Cornelia Brendle, Michael Bitzer, Nisar Malek, Daniel Zips, Ghazaleh Tabatabai
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. Neuro-oncology advances 5 (1) (2023)
Johannes M Weller, N Schäfer, C Schaub, Theophilos Tzaridis, T Zeyen, Matthias Schneider, Anna-Laura Potthoff, F A Giordano, J P Steinbach, P S Zeiner, T Kowalski, M Sabel, P Hau, D Krex, O Grauer, R Goldbrunner, O Schnell, Ghazaleh Tabatabai, Florian Ringel, F Schmidt-Graf, S Brehmer, J C Tonn, L Bullinger, P Vajkoczy, M Glas, H Vatter, U Herrlinger, C Seidel
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial. Journal of neuro-oncology 161 (1) (2023)
Johannes M Weller, N Schäfer, C Schaub, Theophilos Tzaridis, T Zeyen, Matthias Schneider, Anna-Laura Potthoff, F A Giordano, J P Steinbach, P S Zeiner, T Kowalski, M Sabel, P Hau, D Krex, O Grauer, R Goldbrunner, O Schnell, Ghazaleh Tabatabai, Florian Ringel, F Schmidt-Graf, S Brehmer, J C Tonn, L Bullinger, P Vajkoczy, M Glas, H Vatter, U Herrlinger, C Seidel
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial. Journal of neuro-oncology (2023)
Johannes M Weller, N Schäfer, C Schaub, Theophilos Tzaridis, T Zeyen, Matthias Schneider, Anna-Laura Potthoff, F A Giordano, J P Steinbach, P S Zeiner, T Kowalski, M Sabel, P Hau, D Krex, O Grauer, R Goldbrunner, O Schnell, Ghazaleh Tabatabai, Florian Ringel, F Schmidt-Graf, S Brehmer, J C Tonn, L Bullinger, P Vajkoczy, M Glas, H Vatter, U Herrlinger, C Seidel
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial. Journal of neuro-oncology 161 (1) (2023)
Vítor Moura Gonçalves, Elisa-Maria Suhm, Vanessa Ries, Marco Skardelly, Ghazaleh Tabatabai, Marcos Tatagiba, Cornelia Brendle, Felix Behling
Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13 , 466. Cancers 15 (2) (2023)
Sylvia C Kurz, Anja Stammberger, Steffen K Rosahl, Lauren E Abrey, Nathalie L Albert, Louisa V Baumgarten, Bernhard Meyer, Anca-Ligia Grosu, Verena Leidgens, Anna Cecilia Lawson McLean, Mirjam Renovanz, Julia Schwarzenberger, Lisa Sevenich, Tadeja Urbanic Purkart, Stephanie E Combs, Ghazaleh Tabatabai, Monika E Hegi, Martha Nowosielski
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative. Neuro-oncology (2023)
Constantin Roder, Walter Stummer, Jan Coburger, Moritz Scherer, Patrick Haas, Christian von der Brelie, Marcel Alexander Kamp, Mario Löhr, Christina A Hamisch, Marco Skardelly, Torben Scholz, Stephanie Schipmann, Julian Rathert, Catrin Marlene Brand, Andrej Pala, Ulrike Ernemann, Florian Stockhammer, Rüdiger Gerlach, Paul Kremer, Roland Goldbrunner, Ralf-Ingo Ernestus, Michael Sabel, Veit Rohde, Ghazaleh Tabatabai, Peter Martus, Sotirios Bisdas, Oliver Ganslandt, Andreas Unterberg, Christian Rainer Wirtz, Marcos Tatagiba
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Johannes M Weller, N Schäfer, C Schaub, Theophilos Tzaridis, T Zeyen, Matthias Schneider, Anna-Laura Potthoff, F A Giordano, J P Steinbach, P S Zeiner, T Kowalski, M Sabel, P Hau, D Krex, O Grauer, R Goldbrunner, O Schnell, Ghazaleh Tabatabai, Florian Ringel, F Schmidt-Graf, S Brehmer, J C Tonn, L Bullinger, P Vajkoczy, M Glas, H Vatter, U Herrlinger, C Seidel
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial. Journal of neuro-oncology 161 (1) (2023)
Antonio Omuro, Alba A Brandes, Antoine F Carpentier, Ahmed Idbaïh, David A Reardon, Timothy Cloughesy, Ashley Sumrall, Joachim Baehring, Martin J Van Den Bent, Oliver Bähr, Giuseppe Lombardi, Paul Mulholland, Ghazaleh Tabatabai, Ulrik Lassen, Juan Manuel Sepulveda, Mustafa Khasraw, Elodie Vauleon, Yoshihiro Muragaki, Anna Maria Di Giacomo, Nicholas Butowski, Patrick Roth, Xiaozhong Qian, Alex Z Fu, Yanfang Liu, Von Potter, Alexandros-Georgios Chalamandaris, Kay Tatsuoka, Michael Lim, Michael Weller
Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial. Neuro-oncology (2022)
Hannes Becker, Salvador Guillermo Castaneda-Vega, Kristin Patzwaldt, Justyna M Przystal, Bianca Walter, Filippo C Michelotti, Denis Canjuga, Marcos Tatagiba, Bernd J Pichler, Susanne C Beck, Eric C Holland, Christian la Fougère, Ghazaleh Tabatabai
Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma. Brain sciences 12 (11) (2022)
Justyna M Przystal, Hannes Becker, Denis Canjuga, Foteini Tsiami, Nicole Anderle, Anna-Lena Keller, Anja Pohl, Carola H Ries, Martina Schmittnaegel, Nataliya Korinetska, Marilin Koch, Cornelia Brendle, Marcos Tatagiba, Christian Schmees, Susanne C Beck, Ghazaleh Tabatabai
Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma. Cancers 13 (10) (2021)
Antje Wick, Oliver Bähr, Martin Schuler, Kristoffer Staal Rohrberg, Sant P Chawla, Filip Janku, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz-Josef Lenz, Masafumi Ikeda, Yuichi Ando, Wolfgang Wick, Joachim P Steinbach, Michael C Burger, Katharina Johanna Wenger, Ulrik N Lassen, Kamalesh K Sankhala, Cristiana Roggia, Isabelle Genvresse, Catya Munhoz, Christine Rentzsch, Susanne Reschke, Simon Langer, Markus Wagner, Stefan Kaulfuss, Charles Cai, Eleni Lagkadinou, Michael Jeffers, Carol Peña, Ghazaleh Tabatabai
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Hans-Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, Reinhild Klein, Beate Preuß, Juliane Sarah Walz, Annika Nelde, Sebastian P Haen, Michael Reth, Jianying Yang, Ghazaleh Tabatabai, Hans Bösmüller, Helen Hoffmann, Michael Schindler, Oliver Planz, Karl-Heinz Wiesmüller, Markus W Löffler
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups. Vaccines 9 (5) (2021)
Vítor Moura Gonçalves, Elisa-Maria Suhm, Vanessa Ries, Marco Skardelly, Ghazaleh Tabatabai, Marcos Tatagiba, Cornelia Brendle, Felix Behling
Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 13 (3) (2021)
Felix Behling, Christina Fodi, Irina Gepfner-Tuma, Kristina Kaltenbach, Mirjam Renovanz, Frank Paulsen, Marco Skardelly, Jürgen Honegger, Marcos Tatagiba, null null, Cornelia Brendle, Ghazaleh Tabatabai
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort. Neuro-oncology 23 (8) (2021)
Felix Behling, Christina Fodi, Elgin Hoffmann, Mirjam Renovanz, Marco Skardelly, Ghazaleh Tabatabai, Cornelia Brendle, Jürgen Honegger, Marcos Tatagiba
The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy. Neurosurgical review 44 (4) (2020)

Ghazaleh Tabatabai.css-eqlu8i{font-size:small;padding-left:4px;} (G Tabatabai)

Publication Activity (10 Years)

Top Topics

Top Venues

Ghazaleh Tabatabai (G Tabatabai)